MARKET

IXHL

IXHL

Incannex Healthcare Ltd
NASDAQ
3.150
-0.170
-5.12%
After Hours: 3.200 +0.05 +1.59% 19:30 09/28 EDT
OPEN
3.260
PREV CLOSE
3.320
HIGH
3.270
LOW
3.130
VOLUME
131.38K
TURNOVER
--
52 WEEK HIGH
19.71
52 WEEK LOW
2.490
MARKET CAP
39.52M
P/E (TTM)
-0.2441
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IXHL last week (0914-0918)?
Weekly Report · 09/21 10:12
Weekly Report: what happened at IXHL last week (0907-0911)?
Weekly Report · 09/14 10:16
Incannex doses first patient in DReAMzz study
TipRanks · 09/09 12:25
Incannex Begins Phase 2 DReAMzz Sleep Apnea Study
TipRanks · 09/09 12:00
Weekly Report: what happened at IXHL last week (0831-0904)?
Weekly Report · 09/07 10:10
Weekly Report: what happened at IXHL last week (0824-0828)?
Weekly Report · 08/31 10:17
Psychedelic: SciSparc, Clearmind publish patent application for PTSD treatment
TipRanks · 08/27 16:10
Incannex doses first patient in DReAMzz study of IHL-42X
TipRanks · 08/25 12:56
More
About IXHL
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing combination medicines that target the underlying biological pathways associated with chronic conditions, including obstructive sleep apnoea, rheumatoid arthritis, and generalized anxiety disorder. Its lead clinical program, IHL-42X, is an oral fixed-dose combination of dronabinol and acetazolamide designed to target underlying mechanisms and act synergistically in the treatment of obstructive sleep apnoea. IHL-42X has completed a Phase II clinical trial. PSX-001 is a synthetic psilocybin treatment for the treatment of generalized anxiety disorder. PSX-001 has completed a Phase II clinical trial. IHL-675A is an oral fixed-dose combination of cannabidiol and hydroxychloroquine sulfate designed to act synergistically to alleviate inflammatory conditions, such as rheumatoid arthritis. IHL-675A is in a Phase II clinical development program.

Webull offers Incannex Healthcare Inc stock information, including NASDAQ: IXHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IXHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IXHL stock methods without spending real money on the virtual paper trading platform.